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Summary
This report provides recommendations to improve both preconception health and care. The goal of these recommendations is to
improve the health of women and couples, before conception of a first or subsequent pregnancy. Since the early 1990s, guidelines
have recommended preconception care, and reviews of previous studies have assessed the evidence for interventions and docu-
mented the evidence for specific interventions.
CDC has developed these recommendations based on a review of published research and the opinions of specialists from the
CDC/ATSDR Preconception Care Work Group and the Select Panel on Preconception Care. The 10 recommendations in this
report are based on preconception health care for the U.S. population and are aimed at achieving four goals to 1) improve the
knowledge and attitudes and behaviors of men and women related to preconception health; 2) assure that all women of child-
bearing age in the United States receive preconception care services (i.e., evidence-based risk screening, health promotion, and
interventions) that will enable them to enter pregnancy in optimal health; 3) reduce risks indicated by a previous adverse
pregnancy outcome through interventions during the interconception period, which can prevent or minimize health problems for
a mother and her future children; and 4) reduce the disparities in adverse pregnancy outcomes.
The recommendations focus on changes in consumer knowledge, clinical practice, public health programs, health-care financ-
ing, and data and research activities. Each recommendation is accompanied by a series of specific action steps and, when
implemented, can yield results within 2–5 years. Based on implementation of the recommendations, improvements in access to
care, continuity of care, risk screening, appropriate delivery of interventions, and changes in health behaviors of men and women
of childbearing age are expected to occur. The implementation of these recommendations will help achieve Healthy People 2010
objectives. The recommendations and action steps are a strategic plan that can be used by persons, communities, public health
and clinical providers, and governments to improve the health of women, their children, and their families. Improving precon-
ception health among the approximately 62 million women of childbearing age will require multistrategic, action-oriented
initiatives.
Introduction
Improving preconception health can result in improved re-
productive health outcomes, with potential for reducing so-
cietal costs as well (1–4). Preconception care aims to promote
the health of women of reproductive age before conception
and thereby improve pregnancy-related outcomes (5–7).
Therefore, the goals of the 10 recommendations in this re-
port are to improve a woman’s health before conception,
whether before a first or a subsequent pregnancy. The recom-
mendations are 1) individual responsibility across the lifespan,
2) consumer awareness, 3) preventive visits 4) interventions
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for identified risks, 5) interconception care, 6) prepregnancy
checkup, 7) health insurance coverage for women with low
incomes, 8) public health programs and strategies, 9) research,
and 10) monitoring improvements.
Since 1996, progress in the United States to improve preg-
nancy outcomes, including low birthweight, premature birth,
and infant mortality has slowed, in part, because of inconsis-
tent delivery and implementation of interventions before preg-
nancy to detect, treat, and help women modify behaviors,
health conditions, and risk factors that contribute to adverse
maternal and infant outcomes (8). This report discusses sev-
eral interventions that, if implemented before pregnancy, can
improve pregnancy outcomes for women and infants. How-
ever, millions of women and couples do not receive such in-
terventions and services (8).
Childbearing is a common experience among women in
the United States. In 2000, an estimated 62 million U.S.
women were of childbearing age (aged 15–44 years), distrib-
uted in approximately equal segments across the age groups
of 15–24, 25–34, and 35–44 years (9). By age 25 years, ap-
proximately half of all women in the United States have expe-
rienced at least one birth, and approximately 85% of all
women in the United States have given birth by age 44 years.
In 2003, the fertility rate was 66 live births per 1,000 women
aged 15–44 years, with highest rates among women aged 25–
29 years (114 per 1,000) and lowest rates among women aged
>44 years (0.5 per 1,000). A similar age pattern has been ob-
served within racial/ethnic populations, although women aged
<25 years who are non-Hispanic black and Native American
had higher fertility rates than non-Hispanic whites and Asian/
Pacific Islanders. Hispanic women have the highest fertility
rates overall and within each age group (10).
In a 2004 survey of women aged 18–44 years, 84% had a
health-care visit during the previous year, and slightly more
than half (55%) of women of reproductive age obtained pre-
ventive health services in any given year, which are opportu-
nities to deliver preconception care (11). Because
approximately one third to half of women have more than
one primary care provider (i.e., generally a family physician
or internal medicine physician and an obstetrician/
gynecologist) (12), all providers who routinely treat women
for well-woman examinations or other routine visits play an
important role in improving preconception health. However,
only approximately one of six obstetrician/gynecologists or
family physicians had provided preconception care to the
majority of the women for whom they provided prenatal care
(13). Another study reported that mothers frequently inter-
acted with pediatricians after the birth of one child and be-
fore conception of another, which affords another opportunity
to promote preconception health care (14). Community health
centers and other Federally Qualified Health Centers
(FQHC), including primary care and prenatal care, deliver
services to approximately 4.5 million women of childbearing
age each year (15). These centers can be used to provide pre-
conception care to women with low incomes (income <200%
of the federal poverty level) and with no health insurance.
This report provides recommendations to improve both pre-
conception health and preconception health care. Several of
the medical conditions, personal behaviors, psychosocial risks,
and environmental exposures associated with negative pregnancy
outcomes can be identified and modified before conception
through clinical interventions. For certain conditions, oppor-
tunities for preventive interventions occur only before concep-
tion. Establishing preconception health screening as part of
routine care for women of reproductive age has been discussed
in previously published reports (2,5,6,7,13,14). However bet-
ter health care alone will not achieve optimal improvements in
women’s preconception health and reproductive outcomes.
Health promotion activities to modify personal knowledge and
attitudes and behaviors related to reproductive risk factors and
the use of a reproductive life plan for women and couples also
have been proposed (16,17). A reproductive health plan re-
flects a person’s intentions regarding the number and timing of
pregnancies in the context of their personal values and life goals.
This health plan might increase the number of planned preg-
nancies and encourage persons to address risk behaviors before
conception, reducing the risk for adverse outcomes for both
the mother and the infant.
The recommendations should be used by consumers, clini-
cal care providers, public health professionals, researchers,
policy makers, and others concerned with the health of
women, children, and families. Federal, state, and local pub-
lic health agencies can play a vital role in translating these
recommendations into projects, educational materials, and
programs designed to improve preconception health. Primary
care providers serving women of reproductive age, including
obstetrician/gynecologists, family physicians, nurse midwives,
nurse practitioners, and others working in various clinical
settings, have an equally critical role to play in implementing
these recommendations.
CDC developed these recommendations by 1) reviewing
published research; 2) convening the CDC/ASTDR Precon-
ception Care Work Group, representing 22 programs; 3) evalu-
ating presentations of best and emerging practice models at
the National Summit on Preconception Care in 2005; and 4)
convening the Select Panel on Preconception Care (SPPC),
comprised of subject matter specialists on obstetrics and gy-
necology, nursing, public health, midwifery, epidemiology,
dentistry, family practice, pediatrics, and other disciplines.
Various databases (e.g., PubMed® [18]) were searched to iden-
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tify published studies for review. Search parameters included
preconception care, birth outcomes, reproductive health, and
women’s health. The reports were reviewed by the SPPC of
specialists. These recommendations reflect the research, pro-
fessional opinion, practice in medicine, public health, and
related fields, which are sufficient to guide changes in pro-
gram, practice, and policy. SPPC reviewed evidence to deter-
mine the effectiveness of certain interventions of
preconception care (e.g., folic acid to prevent neural tube
defects and cessation of alcohol use) and identified missed
opportunities for dissemination of preconception informa-
tion. Implementation of these effective interventions can con-
tribute to the health of thousands of women each year.
These recommendations are a strategic plan to improve
preconception health through clinical care, individual behav-
ior change, community-based public health programs, and
social marketing campaigns to change consumer knowledge
and attitudes and practices. In addition, they are designed to
increase research knowledge related to preconception health
and care and to improve reproductive health outcomes for all
women and couples. Policy changes at the local, state, and
federal levels will be necessary to support several of these rec-
ommendations. These policies will address changes in access,
payment, and types of services available. Four goals were es-
tablished for achieving these recommendations: 1) improve
the knowledge and attitudes and behaviors of men and women
related to preconception health; 2) assure that all women of
childbearing age in the United States receive preconception
care services (i.e., evidence-based risk screening, health pro-
motion, and interventions) that will enable them to enter preg-
nancy in optimal health; 3) reduce risks indicated by a previous
adverse pregnancy outcome through interventions during the
interconception period, which can prevent or minimize health
problems for a mother and her future children; and 4) reduce
the disparities in adverse pregnancy outcomes.
Preconception Health and Care
Preconception care is recognized as a critical component of
health care for women of reproductive age (1–5,7,16,17,19–
25). The main goal of preconception care is to provide health
promotion, screening, and interventions for women of re-
productive age to reduce risk factors that might affect future
pregnancies (7,16,22–25). Preconception care is part of a larger
health-care model that results in healthier women, infants,
and families (7,16,26–29).
A substantial number of definitions for preconception care
have been used (2–5,16,19,30–33). On the basis of previous
guidelines and recommendations, SPPC developed a refined
definition for preconception care. Preconception care is de-
fined as a set of interventions that aim to identify and modify
biomedical, behavioral, and social risks to a woman’s health
or pregnancy outcome through prevention and management.
Certain steps should be taken before conception or early in
pregnancy to have a maximal effect on health outcomes. Pre-
conception care is more than a single visit to a health-care
provider and less than all well-woman care, as defined by in-
cluding the full scope of preventive and primary care services
for women before a first pregnancy or between pregnancies
(i.e., commonly known as interconception care).
Improving preconception health and pregnancy outcomes
will require more than effective clinical care for women.
Changes in the knowledge and attitudes and behaviors re-
lated to reproductive health among both men and women
need to be made to improve preconception health. Despite
several health promotion campaigns aimed at reducing smok-
ing, misuse of alcohol, intimate partner violence, obesity,
human immunodeficiency virus (HIV)/acquired immunode-
ficiency syndrome (AIDS), reduction of vaccine-preventable
diseases, and exposure to occupational hazards, the majority
of U.S. adults are not aware of how these and other health
and lifestyle factors influence reproductive health and child-
bearing (34,35). Preconception health promotion, therefore,
should focus on a general awareness among men and women
regarding reproductive health and risks to childbearing (26).
Healthy People 2000/2010 Objectives
for Improving Preconception Health
and Guidelines for Preconception Care
A Healthy People 2000 objective (objective 14.3) is for 60%
of primary care physicians to provide age-appropriate pre-
conception care (36). This objective was deleted from Healthy
People 2010 because it was not being measured. Although no
specific objective for preconception exists, several of those
specified in Healthy People 2010 are relevant to preconcep-
tion health (37,38).
The Institute of Medicine, several national committees, and
a substantial number of professional organizations have es-
tablished guidelines and recommendations regarding the im-
portance and content of preconception health care (1,3,4,30–33).
The primary objective of these reports is to improve the health
of women, children, and families. The previously issued
evidence-based guidelines for preconception care have been
summarized and are the foundation for the recommendations
developed by SPPC.
The American Academy of Pediatrics (AAP) and the Ameri-
can College of Obstetricians and Gynecologists (ACOG) have
classified the main components of preconception care into
four categories of interventions: physical assessment, risk
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screening, vaccinations, and counseling. Eight areas of risk
screening are 1) reproductive awareness; 2) environmental
toxins and teratogens; 3) nutrition and folic acid; 4) genetics;
5) substance use, including tobacco and alcohol; 6) medical
conditions and medications; 7) infectious diseases and vacci-
nation; and 8) psychosocial concerns (e.g., depression or vio-
lence) (3,24,26–31,33).
Preconception care should be an essential part of primary
and preventive care, rather than an isolated visit (4,5,21–
26,32,39,40). Whereas a prepregnancy planning visit in the
months before conception has been recommended (3,19,31),
improving preconception health will require changes in the
process of care, including the types of screening and risk-
reduction interventions offered to women of childbearing age.
Guidelines for Perinatal Care, jointly issued by AAP and
ACOG, has recommended that all health encounters during
a woman’s reproductive years, particularly those that are a
part of preconception care, should include counseling on ap-
propriate medical care and behavior to optimize pregnancy
outcomes (41). Recommendations from these organizations
are analogous to the risk screening recommended by the
American Heart Association for cardiovascular disease (42).
Several national organizations have recommended the rou-
tine delivery of preconception care. For example, the March
of Dimes has recommended that the key physician/primary
care provider and the obstetrician/gynecologist take advan-
tage of every health encounter to provide preconception care
and risk reduction before and between conceptions, the time
when health encounters can improve health status (39).
Preconception Risks Associated
with Adverse Pregnancy Outcomes
Risk factors for adverse outcomes among women and in-
fants occur during the preconception period and are character-
ized by the need to start, and sometimes finish, intervention(s)
before conception occurs. In a systematic review, researchers
(43) discussed published reports that identified a list of risk
factors for which preconception care (i.e., risk assessment, health
promotion, and interventions) can be effective.
Women of childbearing age suffer from various chronic
conditions and are exposed to (or consume) substances that
can have an adverse effect on pregnancy outcomes, leading to
pregnancy loss, infant death, birth defects, or other compli-
cations for mothers and infants. For example, in 2002, ap-
proximately 6% of adult women aged 18–44 years had asthma,
50% were overweight or obese, 3% had cardiac disease, 3%
were hypertensive, 9% had diabetes, and 1% had thyroid dis-
order (44). Dental caries and other oral diseases also are com-
mon (>80% of women aged 20–39 years) and associated with
complications for women and infants.
In addition to having chronic diseases, a substantial pro-
portion of women who become pregnant engage in high-risk
behaviors and contribute to adverse pregnancy outcomes. In
2003, a total of 11% of pregnant women smoked during preg-
nancy, a risk factor for low birthweight (10), and 10% of
pregnant women and 55% of women at risk for getting preg-
nant (i.e., those not using contraception or using ineffective
contraceptive methods or using effective contraceptive meth-
ods inconsistently) consumed alcohol, a risk for fetal alcohol
syndrome (45). Certain women also continued to engage in
high-risk sexual behavior, potentially exposing themselves to
sexually transmitted diseases (STDs), including HIV (46).
Although a smaller proportion of women used illicit drugs,
this high-risk behavior has been associated with adverse out-
comes. These behaviors often co-occur, therefore, compound-
ing the risk for adverse outcomes for certain groups.
Immunization for adults and infants is critical for preventing
infectious diseases (e.g., influenza and pertussis).
Data from the Pregnancy Risk Assessment and Monitoring
System (PRAMS) in four states (i.e., Maine, Michigan, Okla-
homa, and West Virginia) indicated that 38% of mothers who
planned pregnancies and an additional 30% who did not plan
pregnancies had one or more indications for preconception
counseling, including use of tobacco or alcohol, being under-
weight, or delayed initiation of prenatal care (47). In Minne-
sota and Washington, data from a telephone survey of women
revealed that pregnancy intention was associated with health
behaviors before pregnancy that might influence pregnancy
outcome, with the most marked differences in smoking and
vitamin use (48).
Preconception health care is critical because several risk be-
haviors and exposures affect fetal development and subsequent
outcomes. The greatest effect occurs early in pregnancy, often
before women enter prenatal care or even know that they are
pregnant (4,23–25,49). For example, for optimal effect on
reducing the risk for neural tube defects, folic acid supple-
mentation should start at least 3 months before conception
(50–52). During the first weeks (before 52 days’ gestation) of
pregnancy, exposure to alcohol, tobacco, and other drugs; lack
of essential vitamins (e.g., folic acid); and workplace hazards
can adversely affect fetal development and results in preg-
nancy complications and poor outcomes for both the mother
and infant (45,53–58). This evidence demonstrates the po-
tential impact of preconception care on the health of women
and their infants.
Social determinants of women’s health also play a role in
pregnancy outcomes. The health status of minority women
with low incomes contributes to persistent, and sometimes
increasing, disparities in birth outcomes. In one study, the
reduced overall health status (including poorer physical and
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emotional health) of women with low income during the
month before pregnancy was associated with an increased risk
for preterm labor (59). Socioeconomic status directly and in-
directly influences three major determinants of health: health-
care access, environmental exposure, and health behavior
(60,61). Racial inequalities in access to effective treatment
also influence these determinants of pregnancy outcomes for
women and infants (62–64).
The following selected preconception risk factors for ad-
verse pregnancy outcomes and evidence for the effectiveness
of preconception care have been used to develop clinical prac-
tice guidelines (e.g., AAP and ACOG).
• Isotretinoins. Use of isotretinoins (e.g., Accutane®) in
pregnancy to treat acne can result in miscarriage and birth
defects. Effective pregnancy prevention should be imple-
mented to avoid unintended pregnancies among women
with childbearing potential who use this medication
(65–67).
• Alcohol misuse. No time during pregnancy is safe to
drink alcohol, and harm can occur early, before a woman
has realized that she is or might be pregnant. Fetal alco-
hol syndrome and other alcohol-related birth defects can
be prevented if women cease intake of alcohol before con-
ception (68–73).
• Anti-epileptic drugs. Certain anti-epileptic drugs are
known teratogens (e.g., valproic acid). Recommenda-
tions suggest that before conception, women who are
on a regimen of these drugs and who are contemplating
pregnancy should be prescribed a lower dosage of these
drugs (74–78).
• Diabetes (preconception). The three-fold increase in the
prevalence of birth defects among infants of women with
type 1 and type 2 diabetes is substantially reduced through
proper management of diabetes (79–82).
• Folic acid deficiency. Daily use of vitamin supplements
containing folic acid has been demonstrated to reduce
the occurrence of neural tube defects by two thirds
(83–88).
• Hepatitis B. Vaccination is recommended for men and
women who are at risk for acquiring hepatitis B virus
(HBV) infection. Preventing HBV infection in women
of childbearing age prevents transmission of infection to
infants and eliminates risk to the woman of HBV infec-
tion and sequelae, including hepatic failure, liver carci-
noma, cirrhosis, and death (89–91).
• HIV/AIDS. If HIV infection is identified before con-
ception, timely antiretroviral treatment can be adminis-
tered, and women (or couples) can be given additional
information that can help prevent mother-to-child trans-
mission (46,92–97).
• Hypothyroidism. The dosages of Levothyroxine® required
for treatment of hypothyroidism increase during early preg-
nancy. Levothyroxine® dosage needs to be adjusted for
proper neurologic development of the fetus (98–100).
• Maternal phenylketonurea (PKU). Women diagnosed
with PKU as infants have an increased risk for delivering
neonates/infants with mental retardation. However, this
adverse outcome can be prevented when mothers adhere
to a low phenylalanine diet before conception and con-
tinue it throughout their pregnancy (101,102).
• Rubella seronegativity. Rubella vaccination provides pro-
tective seropositivity and prevents congenital rubella syn-
drome (49,103,104).
• Obesity. Adverse perinatal outcomes associated with
maternal obesity include neural tube defects, preterm
delivery, diabetes, cesarean section, and hypertensive and
thromboembolic disease. Weight loss before pregnancy
reduces these risks (105–109). Appropriate weight loss
and nutritional intake before pregnancy reduces these
risks.
• Oral anticoagulant. Warfarin, which is used for the con-
trol of blood clotting, has been demonstrated to be a ter-
atogen. To avoid exposure to warfarin during early
pregnancy, medications can be changed to a
nonteratogenic anticoagulant before the onset of preg-
nancy (110–112).
• STD. Chlamydia trachomatis and Neisseria gonorrhoeae
have been strongly associated with ectopic pregnancy,
infertility, and chronic pelvic pain. STDs during preg-
nancy might result in fetal death or substantial physical
and developmental disabilities, including mental retar-
dation and blindness (113,114). Early screening and treat-
ment prevents these adverse outcomes.
• Smoking. Preterm birth, low birthweight, and other ad-
verse perinatal outcomes associated with maternal smok-
ing in pregnancy can be prevented if women stop smoking
before or during early pregnancy. Because only 20% of
women successfully control tobacco dependence during
pregnancy, cessation of smoking is recommended before
pregnancy (115–118).
Several providers and maternal and child health researchers
have recommended that health risks and behaviors be ad-
dressed during any encounter with the health-care system
because approximately half of pregnancies in the United States
are unintended (20,22,27,119,120). One clinical trial has
indicated that provision of preconception care can increase
pregnancy planning and intention (121). This finding is vital
because studies have consistently demonstrated that planned
pregnancies typically have improved outcomes for both
women and infants.
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Preconception Prevention
and Intervention
Since 1987, several reviews of published reports have as-
sessed the evidence and documented the effectiveness for spe-
cific preconception interventions (2,5,33,43). A systematic
review of 21 research trials published during the 1990s have
strengthened the evidence base for preconception care in par-
ticular areas (e.g., folic acid deficiency, maternal PKU, and
oral anticoagulant; 43).
The effectiveness of several interventions that address the
risk factors for adverse outcomes (19,33,43) have been docu-
mented, including folic acid supplementation (51,52,122–
125); appropriate management of hyperglycemia (126–131);
rubella, influenza, and hepatitis vaccination; low phenylala-
nine diet (132–134); and provision of antiretroviral medica-
tions to reduce the risk for mother-to-child HIV transmission
(97). Interventions for smoking and alcohol cessation (135–
139) have been demonstrated to be effective in certain popu-
lations; however, they have been less effective with persons at
highest risk (e.g., injection-drug users and polysubstance
users).
A list of core interventions exist that are part of preconcep-
tion care services. These interventions are risk-specific; pro-
viders can screen and provide appropriate interventions for
persons who need them. However, the best evidence for the
effectiveness of these specific components of preconception
care has been documented when the focus of delivery was on
a single risk behavior and accompanying intervention, rather
than delivery of multiple interventions.
Because of the direct links between a mother’s oral health
and her offspring’s risk for dental caries, dental interventions
can reduce the risk for prematurity and low birthweight (140–
143). Evidence supporting interventions to reduce mother-
to-child transmission of cariogenic bacteria supports
recommendations for the appropriate use of fluorides and
dietary control to reduce maternal salivary reservoirs of cari-
ogenic bacteria, particularly for women who have experienced
high rates of dental caries (140).
Interventions that address multiple pregnancy-related risk
behaviors simultaneously have not been systematically evalu-
ated and are less commonly delivered. The U.S. Preventive
Services Task Force (USPSTF) evaluated the effectiveness of
interventions related to smoking, alcohol misuse, and obe-
sity, based on studies of interventions delivered in primary
care settings that were not complicated by the additional de-
livery of multiple components of preconception care
(69,70,144–147). These effective methods for intervention
(e.g., the Five As [Ask, Advise, Assess, Assist, and Arrange])
for smoking cessation and brief counseling interventions to
reduce alcohol misuse, as identified by USPSTF, provide
models for the delivery of multiple interventions that can be
adapted and tested (69,70). One study has reported the effec-
tiveness of comprehensive preconception care; however, the
findings have limited applicability for the implementation of
preconception health-care services in the United States be-
cause the study was conducted in Hungary (147).
One priority for preconception care activities is to ensure
that evidence-based interventions are implemented to further
improve infant and maternal pregnancy outcomes among
women living with chronic conditions. Clinical practice guide-
lines (CPGs) for preconception care for specific maternal
chronic health conditions have been developed by several
national health professional groups (25–28). For example, the
American Diabetes Association has developed CPGs that
should be followed before pregnancy for women with diabe-
tes (81). The American Association of Clinical Endocrinolo-
gists has developed CPGs for women with hypothyroidism
who are attempting to conceive (100). CPGs have also been
developed for women being treated with teratogenic medica-
tions to guide the transition to safer medications. CPGs for
women considering pregnancy and who are using anti-
epileptic drugs or oral anticoagulants have been developed by
the American Academy of Neurology (77) and the American
Heart Association/American College of Cardiologists (78),
respectively.
Whereas the evidence supporting specific interventions and
the importance of intervening before pregnancy are defini-
tive, limited evidence is available to determine effective meth-
ods for delivering preconception care and improving
preconception health. Only a limited number of studies re-
garding effectiveness of interventions have been tested for in-
creasing preconception screening, counseling, and intervention
in primary care settings (121,148,149). In one randomized
clinical trial, preconception risk factors were identified among
women who sought care at a hospital primary care clinic for a
pregnancy test. In this trial, an average of nine risk factors per
woman was identified at the time of a negative pregnancy
test. However, notifying women and their clinicians of iden-
tified preconception risks did not improve intervention rates
(148). In another study in which didactic lectures and chart
cues were used, significant increases occurred in risk screen-
ing for medical risk factors (15%–44%), medications (10%–
30%), domestic violence (10%–57%), and nutrition (9%–
50%) among nonpregnant women who attended an inner-
city hospital gynecologic clinic. However, intervention rates
and provider attitudes toward preconception care did not
change substantially (149). A prospective study of the effect
of preconception health promotion on intendedness of preg-
nancy revealed that women in a family planning clinic who
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had received the intervention (22%) during routine visits were
more likely to report intended pregnancies than those patients
in the same clinic who were not exposed to the intervention
(15) (121).
A limited number of studies have assessed the best methods
for integrating interventions to achieve maximum impact and
optimize the use of limited resources. As with other types of
preventive care services, time constraints limit physicians’
ability to deliver health promotion interventions (144). Pre-
conception care interventions can potentially be integrated
into a limited number of model visits to focus on specific
content at different visits, as is done for well-child care (150).
Integrated and coordinated care services might also provide
additional support to improve health outcomes. For example,
an evaluation of the quality of care in the National Centers of
Excellence in Women’s Health indicated that women served
in these centers, compared with community samples, received
more clinical preventive services and had higher satisfaction
levels (151). Another approach (e.g., self-management) to
integrated service of delivery has been illustrated in CDC’s
recommendations in Strategies for Reducing Morbidity and
Mortality from Diabetes Through Health-Care System Interven-
tions and Diabetes Self-Management Education in Community
Settings: A Report on Recommendations of the Task Force on
Community Preventive Services (152). HIV intervention ef-
forts also have suggested that integrated interventions address
substance use and reduce sexual risk behaviors simultaneously.
The purpose of preconception care is to deliver risk screen-
ing, health promotion, and effective interventions as a part of
routine health care. In the United States, this approach is the
standard used to achieve prevention of vaccine-preventable
disease, heart disease, diabetes, and other chronic conditions.
This approach is similar to well-child care, prenatal care, and
adult wellness care in which studies have demonstrated the
effectiveness of individual components rather than the effec-
tiveness of combined interventions. However, effectiveness
depends on ongoing monitoring of health status with
interventions.
Preconception care should be tailored to meet the needs of
the individual woman. Because preconception care needs to
be provided across the lifespan and not during only one visit,
certain recommendations will be more relevant to women at
different life stages and with varying levels of risk. Health
promotion, risk screening, and interventions are different for
a young woman who has never experienced pregnancy than
for a woman aged 35 years who has had three children. Women
with chronic diseases, previous pregnancy complications, or
behavioral risk factors might need more intensive interven-
tions. Such variations also place constraints on how interven-
tions can and should be integrated.
Context and Frame Work
for Recommendations
The recommendations are designed to promote optimal
health throughout the lifespan for women, children, and fami-
lies by using both clinical care and population-focused pub-
lic health strategies. In this report, the approach to promoting
preconception health is not a single clinical visit but a process
of care and interventions designed to address the needs of
women during the different stages of reproductive life. SPPC
has encouraged the use of a broad definition of prenatal care
that includes ongoing preconception interventions, the addi-
tion of a prepregnancy visit, multiple postpartum visits, and
the currently recommended prenatal care visits. Preconcep-
tion care offers health services that allow women to maintain
optimal health for themselves, choose the number and spac-
ing of their pregnancies and, when desired, prepare for a
healthy baby. Interventions and health care that occur before
and between pregnancies are included in this report. This re-
view identified areas for which further research is needed (43).
Increasing evidence-based research of clinical and public health
interventions by using both qualitative and quantitative meth-
ods is essential to the fulfillment of these recommendations.
Each of the 10 recommendations has specific action steps
that can be implemented in the next 2–5 years. Increasing
access to and use of preconception care will not occur imme-
diately; diffusion of innovation theory demonstrates how
slowly concepts and best practices are typically disseminated
(153,154). The action steps recommend revision of profes-
sional standards of care, modification of provider behaviors,
development of effective health promotion messages, changes
in consumer behavior, and adjustments to payment mecha-
nisms. In addition, the recommendations emphasize indi-
vidual behavior and responsibility for improving
preconception health and identify specific evidence-based
strategies for modifying individual knowledge and attitudes
and behaviors across the lifespan. The recommendations pro-
mote changes in clinical care, public health programs at the
federal, state, and local levels, and other community-based
programs. For example, quality improvement strategies, com-
monly used today in clinical practice, might be used to modify
provider knowledge and attitudes and behaviors. In addition
to participation among traditional partners in public health
interventions, improving preconception health will require
increased involvement from partners in various sectors (e.g.,
education, housing, urban planning, and environmental
health). These partners should be included as part of the com-
prehensive solution to improve women’s health and the health
of families. Approaches to improve surveillance, performance
monitoring, and results accountability have been recom-
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mended along with strategies to integrate care, develop
complementary approaches, and reduce duplication of activi-
ties among different professional and programmatic stake-
holders.
The risk and the burden of disease is unequally distributed,
and a small number of women experience the majority of the
pregnancy-related morbidity and mortality, which suggests
that a two-step approach to implementing interventions would
be beneficial. The first step would target women at highest
risk (whether the risks are biologic or social) to reduce mor-
bidity and mortality. The second step would aim to improve
preconception health for all women of reproductive age, re-
gardless of risk status. The recommendations emphasize tar-
geting interventions for groups of women with known risks
and conditions (e.g., those with previous poor pregnancy
outcomes or chronic conditions).
Culturally and linguistically appropriate systems of care are
needed to ensure maximal use and impact of preconception
health-care services. By increasing the acceptability, effective-
ness, and impact of the health-care system through these
changes, persons involved in improving preconception health
care have the opportunity to address and reduce health dis-
parities.
The recommendations are a starting point to make com-
prehensive preconception care a standard of care in the United
States and to provide a more universal, comprehensive,
evidence-based model of preconception care. The recommen-
dations will promote the development and practice of pre-
conception care that will be flexible to meet persons’ changing




The recommendations were developed through the collabo-
rative efforts of CDC and external partners to 1) target life
stages in reproductive-aged women; 2) encourage special in-
terest groups to collaborate to achieve common goals; 3) en-
courage scientific and public health collaboration; and 4)
address health impact, public health systems, efficiency, and
effectiveness.
During 2003, a review of studies published regarding ma-
ternal and child health and preconception care was conducted
by CDC to assess preconception care. The CDC work group
also discussed opportunities for collaboration across programs.
Several CDC programs in the work group had previously
identified specific interventions with scientific evidence which,
if delivered before conception, would promote preconcep-
tion health and improve pregnancy-related outcomes. These
programs recognized the need to integrate these interventions
with similar services to improve coverage, effectiveness, access,
efficiency, and ultimately maternal and infant pregnancy out-
comes. The need for preconception health promotion and
care was identified as a critical public health topic by CDC
and partners. As a result, a broader working group of national
organizations involved in preconception health issues were
established (Appendix).
In November 2004, the CDC work group and representa-
tives of 16 external organizations discussed the evidence sup-
porting preconception care to determine the steps that can be
taken to develop national recommendations. The consensus
of the participants was that a larger meeting on preconcep-
tion care and an interdisciplinary panel of specialists should
be convened in 2005. A steering committee and planning
committee were established (including representatives from
CDC and external partners) to plan for a national summit
and to bring together a group of specialists with experience in
data, practice, and policy issues related to preconception
health.
In June 2005, a national summit on preconception care
was convened to gather information concerning promising
practice models. The summit agenda was developed based on
68 submitted abstracts and reflected various preconception
project models, finance approaches, and research questions
(CDC, unpublished data, 2005).
In conjunction with the summit, CDC convened SPPC,
which included various subject matter specialists and repre-
sentatives from national organizations concerned about the
health of women, infants, and families. A Delphi technique
was used to identify subject matter specialists to serve on
SPPC. SPPC discussed recommendations regarding clinical
practice, public health/community programs, research/data,
and policy/finance.
Initial recommendations were sent to the CDC work group,
panel members, and additional subject matter specialists from
academic and professional backgrounds for comment and
review. Reviewers shared their comments in writing or as part




Ten recommendations were developed for improving pre-
conception health through changes in consumer knowledge,
clinical practice, public health programs, health-care financ-
ing, and data and research activities. Each recommendation
has specific action steps. If each action step is implemented,
benefits might be observed within 2–5 years, which would
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Box 1. Recommendation 1 preconception health action steps
• Develop, evaluate, and disseminate reproductive life
planning tools for women and men in their childbear-
ing years, respecting variations in age; literacy, includ-
ing health literacy; and cultural/linguistic contexts.
• Conduct research leading to development, dissemina-
tion, and evaluation of individual health education
materials for women and men regarding preconception
risk factors, including materials related to biomedical,
behavioral, and social risks known to affect pregnancy
outcomes.
help achieve the Healthy People 2010 objectives to improve
maternal and child health outcomes. The recommendations
are aimed at achieving four goals, based on personal health
outcomes.
Goal 1. Improve the knowledge and attitudes and behav-
iors of men and women related to preconception health.
Goal 2. Assure that all women of childbearing age in the
United States receive preconception care services (i.e.,
evidence-based risk screening, health promotion, and inter-
ventions) that will enable them to enter pregnancy in optimal
health.
Goal 3. Reduce risks indicated by a previous adverse preg-
nancy outcome through interventions during the
interconception period, which can prevent or minimize health
problems for a mother and her future children.
Goal 4. Reduce the disparities in adverse pregnancy
outcomes.
The recommendations are a strategic plan for improving
the health of women, their children, and their families and
are based on existing knowledge and evidence-based practice.
Improving preconception health among the estimated 62
million women of childbearing age (9) will require a
multistrategy, action-oriented initiative.
The recommendations, which are not prioritized, should
be used by consumers, public health and clinical providers,
researchers, and policy makers. Therefore, the recommenda-
tions should be implemented simultaneously. In the action
steps, persons, public health and clinical providers, commu-
nities, governments (i.e., local, state, and federal), and profes-
sional organizations all have roles. Finally, these
recommendations are designed to reduce disparities in ma-
ternal and infant health by improving the preconception health
of women and men.
Recommendations
Recommendation 1. Individual Responsibility Across the
Lifespan. Each woman, man, and couple should be
encouraged to have a reproductive life plan.
The target population for preconception health promotion
is women, from menarche to menopause, who are capable of
having children, even if they do not intend to conceive. To
reach such a broad group, a lifespan perspective is needed
(3,17,20), which is commonly used in efforts to reduce chronic
diseases, particularly cardiovascular disease. For example, per-
sons are encouraged to consider the role of genetic and di-
etary factors in determining their risk for high cholesterol
and to modify their behaviors according to cumulative indi-
vidual risks (e.g., changes in diet, exercise, or medications)
(155). Similarly, a lifespan approach can be used to focus in-
dividual attention on reproductive health to reduce unin-
tended pregnancies, age-related infertility, fetal exposures to
teratogens, and to improve women’s health and pregnancy
outcomes (20).
Certain researchers, providers, and health-care advocates
have suggested developing a reproductive health life plan for
young women and couples as they enter their reproductive
years. However, reproductive health life plans have not been
systematically implemented and evaluated (23,26,29,33).
Implementing such a reproductive health life plan will re-
quire a change in provision of health services and health pro-
motion (Box 1).
Recommendation 2. Consumer Awareness. Increase public
awareness of the importance of preconception health behaviors
and preconception care services by using information and tools
appropriate across various ages; literacy, including health
literacy; and cultural/linguistic contexts.
Consumers should be more involved in improving precon-
ception care services. Knowledge and attitudes and behaviors
related to reproductive health are influenced by childhood
experiences and prevailing social norms among adults. Cer-
tain U.S. adults are not aware of the factors that influence
reproductive health and childbearing (34,35). The precon-
ception guidelines from Canada state that preconception care
is 1) physical preparation for pregnancy and parenting and 2)
the social, psychological, and spiritual components of preg-
nancy. The factors that influence attitudes regarding precon-
ception care include a person’s age and life stage, their
childbearing history, and their life priorities (156).
Activities specifically designed to improve school general
health education are an essential step in improving reproduc-
tive awareness. Efforts to inform adults regarding the risks
and opportunities to improve their health are equally impor-
tant. Several health promotion campaigns provide opportu-
nities to change adult knowledge and attitudes and behaviors,
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• Develop, evaluate, and disseminate age-appropriate edu-
cational curricula and modules for use in school health
education programs.
• Integrate reproductive health messages into existing
health promotion campaigns (e.g., campaigns to reduce
obesity and smoking).
• Conduct consumer-focused research to identify terms that
the public understands and to develop messages for pro-
moting preconception health and reproductive awareness.
• Design and conduct social marketing campaigns neces-
sary to develop messages for promoting preconception
health knowledge and attitudes, and behaviors among
men and women of childbearing age.
• Engage media partners to assist in depicting positive
role models for lifestyles that promote reproductive
health (e.g., delaying initiation of sexual activity, ab-
staining from unprotected sexual intercourse, and avoid-
ing use of alcohol and drugs).
Box 2. Recommendation 2 preconception health action stepsincluding campaigns designed to reduce tobacco use, pro-
mote responsible use of alcohol, and encourage healthy diet
and optimal weight. Campaigns can include messages con-
cerning reproductive health and childbearing. Such campaigns
typically focus on the effect of adverse behaviors on children
and do not include parallel messages regarding the potential
impact on childbearing. New social marketing and health
promotion campaigns that focus on how to prepare for child-
bearing and parenting can influence the behavior of men and
women. For example, folic acid intake has been promoted
among women of childbearing age (123). Similar to efforts
to reduce teenage childbearing or increase use of prenatal care,
the media can play a vital role in promoting reproductive
awareness (157).
Success in improving preconception health will require
changes in public attitudes and has been achieved in other
areas (e.g., attitudes changed during the previous 10 years
regarding tobacco use, infant sleep position, or vaccinations
for infants and toddlers instead of preschoolers) (158). A criti-
cal tool for stimulating these changes is social marketing, which
is designed to influence the voluntary behavior of targeted
audiences to improve their well-being (159,160).
Consumer-friendly tools can help women self-assess risks,
make plans, and take actions that will improve their health
and that of their children. More consumer-focused research
is needed to determine which messages and tools might be
effective to encourage reproductive life planning. The SPPC
members have suggested that such research explore which
terms the public best understands, what messages might in-
crease demand for services, and how touch-screen kiosks or
other technology might be used to promote knowledge of
preconception health topics (Box 2).
Recommendation 3. Preventive Visits. As a part of primary
care visits, provide risk assessment and educational and health
promotion counseling to all women of childbearing age to
reduce reproductive risks and improve pregnancy outcomes.
Integration of preconception components into primary care
can better serve women across their lifespan and at various
levels of risk. Primary care integrates various health promo-
tion, prevention, and acute care services to address the major-
ity of personal health-care needs and common health problems
in a community setting. Primary care also might include
screening for and ongoing management of chronic conditions
in a primary care setting. Elements of preconception care can
be integrated into every primary care visit.
Professional guidelines for clinicians (i.e., obstetrician/gy-
necologists, family practice physicians, certified nurse mid-
wives, and nurse practitioners) who provide the majority of
primary care to women in the United States should include
routine risk assessment through screening (14,24,28,29,33).
Different guidelines recommend eight to 10 specific areas for
preconception risk assessment, including: 1) reproductive his-
tory; 2) environmental hazards and toxins; 3) medications
that are known teratogens; 4) nutrition, folic acid intake, and
weight management; 5) genetic conditions and family his-
tory; 6) substance use, including tobacco and alcohol; 7)
chronic diseases (e.g., diabetes, hypertension, and oral health);
8) infectious diseases and vaccinations; 9) family planning;
and 10) social and mental health concerns (e.g., depression,
social support, domestic violence, and housing)
(5–7,30,31,33,40,41).
In addition to risk assessment or screening, professional
guidelines include health promotion education and counsel-
ing related to reproductive health risks. Such activities should
routinely include promotion of healthy behaviors; discussion
of child spacing, family planning, and unintended pregnancy
prevention; counseling concerning healthy diet, folic acid
supplementation, and optimal weight; immunization for in-
fectious disease; information regarding the importance of early
prenatal care; and counseling concerning the availability of
social and financial support programs.
For women with identified risks, additional counseling, test-
ing, and brief interventions (e.g., for smoking, alcohol, or
changes in prescription medications) can be conducted in the
primary care setting (68–70,116–118). Certain women will
need additional intensive interventions and specialty care.
Whereas evidence and clinical guidelines exist that support
several preconception care interventions, data are needed to
determine the effectiveness of integrating those interventions
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• Increase health provider (including primary and
specialty care providers) awareness regarding the im-
portance of addressing preconception health among all
women of childbearing age.
• Develop and implement curricula on preconception care
for use in clinical education at graduate, postgraduate,
and continuing education levels.
• Consolidate and disseminate existing professional guide-
lines to develop a recommended screening and health
promotion package.
• Develop, evaluate, and disseminate practical screening
tools for primary care settings, with emphasis on the 10
areas for preconception risk assessment (e.g., reproduc-
tive history, genetic, and environmental risk factors).
• Develop, evaluate, and disseminate evidence-based mod-
els for integrating components of preconception care
to facilitate delivery of and demand for prevention
and intervention services.
• Apply quality improvement techniques (e.g., conduct
rapid improvement cycles, establish benchmarks and
brief provider training, use practice self-audits, and par-
ticipate in quality improvement collaborative groups)
to improve provider knowledge and attitudes, and prac-
tices and to reduce missed opportunities for screening
and health promotion.
• Use the federally funded collaboratives for community
health centers and other Federally Qualified Health
Centers to improve the quality of preconception risk
assessment, health promotion, and interventions pro-
vided through primary care.
• Develop fiscal incentives for screening and health
promotion.
Box 3. Recommendation 3 preconception health action steps(e.g., a limited number of model visits), as is done for well-
child care.
Clinical practice can be influenced by evidence-based guide-
lines, but additional strategies are needed to promote wide-
spread adoption of professional guidelines (25,30–33,151–154).
In the recommended action steps (Box 3), additional activi-
ties should be provided to support changes in primary care
provider knowledge and attitudes and practices. Consolida-
tion of existing guidelines, better tools, and use of quality
improvement techniques have fostered changes in knowledge
and practices (161–164). For example, the Bright Futures
Program has consolidated guidelines for child health, and the
Bright Futures for Women’s Health and Wellness offers mod-
els and opportunities for links to preconception care (165).
Community health centers and other FQHC can be a key
point of dissemination for strategies to improve preconcep-
tion health. FQHC are a critical source of primary care for
millions of women with low incomes and no insurance. Peri-
natal care for 332,000 women account for one of every 10
U.S. births (166). Among FQHC, the Health Disparities
Collaboratives (HDC) Initiative is designed to improve the
quality of primary care delivered, and approximately 600
FQHCs have participated (167). The HDC model relies on
partnerships among community clinics, federal agencies, and
national organizations. HDC started with a chronic disease
care model for quality improvement, and a primary health-
care model integrated with the perinatal care collaboratives
and other efforts has been developed.
Recommendation 4. Interventions for Identified Risks.
Increase the proportion of women who receive interventions
as follow-up to preconception risk screening, focusing on high
priority interventions (i.e., those with evidence of effectiveness
and greatest potential impact).
Timely preconception interventions for certain conditions
can substantially improve maternal health and birth outcomes
(4,43). Separating childbearing from the management of
chronic health problems and infectious diseases places women,
their future pregnancies, and their future children at unnec-
essary risk (7,20,24,149). Conditions and risk factors have
been identified for which the following exist 1) evidence of
potential harm to mother or baby, 2) high prevalence of ad-
verse pregnancy outcome or effective interventions for reduc-
ing adverse pregnancy outcomes, and 3) one or more effective
interventions that have been evaluated.
Certain women and men need additional counseling and
interventions. For example, women who have conditions
treated with medications that are known teratogens (e.g., an-
ticonvulsant or anticoagulant medications and isotretinoins)
might need to change prescriptions. Women with medical
conditions associated with increased risks for morbidity and
mortality to mother and fetus (e.g., diabetes, hypertension,
heart disease, rubella sero-negativity, thrombophilias, dental
disease, or obesity) need to control these conditions. Women
with behaviors associated with increased health risks for the
fetus (e.g., smoking and alcohol and illicit drug use) also need
targeted interventions. Another group with specific counsel-
ing needs includes prospective parents with a family history
of inherited (i.e., genetic) disorders.
The preparers of this report analyzed the National Ambu-
latory Medical Care Survey (168) and demonstrated that dia-
betes affects approximately 1.85 million (21 per 1,000) women
in the United States aged 18–44 years, and that
preconceptional diabetes management has the potential to
reduce the risk for pregnancy loss and congenital malforma-
tion for approximately 113,000 births per year. Anti-epileptic/
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• Increase health provider (including primary and spe-
cialty care providers) awareness concerning the impor-
tance of ongoing care for chronic conditions and inter-
vention for identified risk factors.
• Develop and implement modules on preconception care
for specific clinical conditions for use in clinical educa-
tion at graduate, postgraduate, and continuing educa-
tion levels.
• Consolidate and disseminate existing guidelines related
to evidence-based interventions for conditions and risk
factors.
• Disseminate existing evidence-based interventions that
address risk factors that can be used in primary care
settings (i.e., iotretinoins, alcohol misuse, anti-
epileptic drugs, diabetes [preconception], folic acid de-
ficiency, hepatitis B, HIV/AIDS, hypothyroidism, ma-
ternal phenylketonurea [PKU], rubella seronegativity,
obesity, oral anticoagulant, STD, and smoking).
• Develop fiscal incentives (e.g., pay for performance) for
risk management, particularly in managed care settings.
• Apply quality improvement techniques and tools (e.g.,
conduct rapid improvement cycles, establish bench-
marks, use practice self-audits, and participate in qual-
ity improvement collaborative groups).
Box 4. Recommendation 4 preconception health action stepsantiseizure drugs are prescribed for approximately 1 million
women (19 per 1,000), potentially affecting an estimated
75,000 pregnancies. Approximately 7 million (125 per 1,000)
women of childbearing age are frequent drinkers, and with-
out preconception interventions, alcohol misuse might affect
approximately 577,000 births per year (168). Women with
chronic medical conditions and their specialty providers
should take advantage of every opportunity to discuss pre-
conception health and risks. These conditions and risk fac-
tors affect substantial proportions of the approximately 4
million pregnancies that occur in the United States each year.
Studies of preconception care have indicated that providers
do not routinely provide interventions for identified precon-
ception risks (23,147,148,164,169). Dissemination of pro-
fessional guidelines and evidence-based interventions are two
vital ways to encourage changes in practice. However, quality
improvement tools and techniques offer increased potential,
particularly for specific interventions for women with identi-
fied conditions (162,170). Research has increasingly indicated
that providers and health-care organizations are more likely
to engage in evidence-based or best clinical practices, after
participation in quality improvement projects (e.g., rapid
improvement cycles using the plan/do/study/act approach,
collaborative groups, or the model of improvement process
that involves an aim/change/measure cycle) (162,170). In-
corporation of preconception care modules into the curricula
of medical graduate, postgraduate, and continuing medical
education might be another method of disseminating mes-
sages regarding the importance and content of preconception
care for women (Box 4).
Recommendation 5. Interconception Care. Use the
interconception period to provide additional intensive
interventions to women who have had a previous pregnancy
that ended in an adverse outcome (i.e., infant death, fetal loss,
birth defects, low birthweight, or preterm birth).
Experiencing an adverse outcome in a previous pregnancy is
an important predictor of future reproductive risk (171–173).
However, many women with adverse pregnancy outcomes do
not receive targeted interventions to reduce risks during future
pregnancies. Each year, approximately 28,000 infants die dur-
ing the first year of life (171). Approximately 12% of all births
are preterm (i.e., <37 weeks’ gestation) (10), and an estimated
3% of infants are born with birth defects (174). Whereas a
preterm birth is identified on birth certificates and a woman’s
primary care provider typically knows this information, pro-
fessional guidelines do not include systematic follow-up and
intervention for women with this critical predictor of risk.
Postpartum visits are an opportunity to link women to inter-
ventions designed to reduce risks to them and their future chil-
dren, and promising strategies focus on the postpartum period
(170). The Health Employer Data and Information Set
(HEDIS), used by public and private health plans, has mea-
sures for postpartum visits. HEDIS data indicate that 80% of
women with private (i.e., commercial) insurance coverage and
55% of those covered by Medicaid receive postpartum check-
ups. However, for the majority of health plans, strategies to
encourage compliance or address low rates of return for post-
partum care have not been implemented (44). Measures for
monitoring postpartum visits also are used by a limited num-
ber of state Title V Maternal Child Health Block Grant agen-
cies (175). Data collected during postpartum visits typically
have not been used to guide health-care system planning.
Approaches to interconception care, which are part of pre-
conception care, have been proposed (176,177), and certain
approaches have been tested. For example, in the
Interpregnancy Care Program of Grady Memorial Hospital
in Atlanta, Georgia, researchers have been studying the effec-
tiveness of interconception care in improving subsequent re-
productive outcomes for women who have delivered a baby
born at very low birthweight (<1,500 grams). This model fo-
cuses on reducing identified medical, dental, and
psychosocial risks and assisting women in developing and
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• Monitor the percentage of women who complete post-
partum visits (e.g. using the Health Employer Data and
Information Set measures for managed care plans and
Title V Maternal Child Health Block Grant state mea-
sures), and use these data to identify communities of
women at risk and opportunities to improve provider
follow-up.
• Develop, evaluate, and replicate intensive evidence-based
interconception care and care coordination models for
women at high social and medical risk.
• Enhance the content of postpartum visits to promote
interconception health.
• Use existing public health programs serving women in
the postpartum period to provide or link to interven-
tions (e.g., family planning, home visiting, and the
Special Supplemental Nutrition Program for Women,
Infants, and Children).
• Encourage additional states to develop preconception
health improvement projects with funds from the Title
V Maternal Child Health Block Grant, Prevention Block
Grant, and similar public health programs.
Box 5. Recommendation 5 preconception health action steps
• Consolidate existing professional guidelines to develop
the recommended content and approach for such a visit.
• Modify third party payer rules to permit payment for
one prepregnancy visit per pregnancy, including devel-
opment of billing and payment mechanisms.
• Educate women and couples regarding the value and
availability of prepregnancy planning visits.
Box 6. Recommendation 6 preconception health action steps
achieving their reproductive goals for the future. During the
pilot phase, the program identified and treated various medi-
cal conditions and reported substantial positive impact on
the length of birth intervals (177). The federal Healthy Start
program requires that a grantee follow a woman and her child
for 2 years postpartum, providing interconception care. In
addition, certain Healthy Start grantees provide more in-depth
interconception services to women at high risk to reduce fu-
ture adverse pregnancy outcomes (175). Across the United
States, Healthy Start grantees (e.g., the Magnolia Project in
northeastern Florida) are providing intensive postpartum case
management for women at high risk for adverse pregnancy
outcomes (178–179). Opportunities are available to identify,
refer, and serve women at high risk in the Special Supplemen-
tal Nutrition Program for Women, Infants, and Children
(WIC) nutrition sites, family planning clinics, and home vis-
iting programs (175). Federal and state agencies can support
such efforts with funding for demonstration, evaluation, and
replication projects (Box 5).
Recommendation 6. Prepregnancy Checkup. Offer, as a
component of maternity care, one prepregnancy visit for
couples and persons planning pregnancy.
SPPC encourages the use of a broad definition of mater-
nity care that includes the addition of a prepregnancy visit
and the recommended prenatal and postpartum visits. The
addition of this prepregnancy visit is an essential step toward
improving pregnancy outcomes, particularly for those plan-
ning pregnancy.
The Institute of Medicine Panel on Preventing Low
Birthweight, the U.S. Public Health Service Expert Panel on
the Content of Prenatal Care, and the national Committee
on Perinatal Health have recommended that women have a
prepregnancy visit (i.e., sometimes called a preconception visit)
in the months before conception (1,3,4). Such visits would
include preconception care content, providing women an
opportunity to benefit from risk assessment, health promo-
tion, and specific interventions related to circumstances when
couples are trying to conceive. Adoption of the prepregnancy
visit as a standard of care also can help to reinforce the impor-
tance of pregnancy planning and preparedness among women
and men (Box 6).
Recommendation 7. Health Insurance Coverage for
Women with Low Incomes. Increase public and private
health insurance coverage for women with low incomes to
improve access to preventive women’s health and preconception
and interconception care.
Affordability of care is a major concern for multiple women
(11,180,181), and improved access to preconception care is
needed. Approximately 17 million women do not have health
insurance, and they are more likely to postpone or forgo care
(180). During 2003, one third of women with low incomes,
half of women with disabilities, and 18% of all nonelderly
(aged <65 years) women did not have health insurance (180).
Younger women aged 18–34 years were more likely than older
women not to have health insurance during 2003. Reflecting
their income and employment status patterns (i.e., more likely
to have incomes <200% of poverty level and less likely to be
employed in jobs that offer health insurance), non-Hispanic
white, Asian, and non-Hispanic black women were more likely
than non-Hispanic white women not to have health
insurance (11,180,181).
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• Improve the design of family planning waivers by per-
mitting states (by federal waiver or by creating a new
state option) to offer interconception risk assessment,
counseling, and interventions along with family plan-
ning services. Such policy developments would create
new opportunities to finance interconception care.
• Increase health coverage among women who have low
incomes and are of childbearing age by using federal
options and waivers under public and private health
insurance systems and the State Children’s Health In-
surance Program.
• Increase access to health-care services through policies
and reimbursement levels for public and private health
insurance systems to include a full range of clinicians
who care for women.
Box 7. Recommendation 7 preconception health action steps
Medicaid is the primary mechanism for extending health
coverage to women with low incomes and who do not have
health insurance. During 2003, a total of 12% of all women
of childbearing age and 37% of women with low incomes in
that age group relied on Medicaid for health-care coverage
(181,182). Medicaid has been demonstrated to be effective
in improving access to health care for women with low in-
comes (179). Because nearly two thirds (63%) of women cov-
ered by Medicaid are of childbearing age, the program’s
performance is related to preconception care access and to
the outcomes of pregnancy (183). Many women with low
incomes, however, do not qualify for Medicaid because they
do not have children aged <18 years or do not have docu-
mentation of legal residence in the United States. As states
seek to expand Medicaid coverage to persons with low in-
comes and adults who do not have health insurance, women
of childbearing age should receive priority for qualifying for
Medicaid coverage.
Since 1995, a total of 22 states have used their federal waiver
authority to expand family planning services to women who
do not otherwise qualify for Medicaid, known as family plan-
ning waivers. Certain states offer coverage to women who
lose coverage after the birth of a baby or starting a job, whereas
other states offer family planning coverage based on the in-
come status of men and women (182). An evaluation of these
family planning waiver projects prepared for the federal Center
for Medicare and Medicaid Services indicated that the projects
resulted in substantial savings to both the federal and state gov-
ernments (184). Increased potential savings and prevention,
however, can result if states provided coverage for more com-
prehensive risk screening, health promotion, and interventions,
resulting in higher levels of preconception wellness (Box 7).
Recommendation 8. Public Health Programs and
Strategies. Integrate components of preconception health into
existing local public health and related programs, including
emphasis on interconception interventions for women with
previous adverse outcomes.
Public health programs serve millions of women each year.
Preconception interventions can be incorporated into these
programs to target women at highest risk. Title X family plan-
ning programs provide approximately 4.6 million women with
family planning education and contraceptives and pregnancy
tests. However, a limited number of programs offer more com-
prehensive risk screening, reproductive health promotion, and
reproductive life planning (185). Each year, WIC provides
nutrition screening and counseling, supplemental food, and
referrals to health services for approximately 8 million women
during pregnancy and the postpartum period (186). These
services provide an opportunity to promote preconception
health and refer women at risk to clinicians. Federal and state
public health programs funded by the Title V Maternal and
Child Health Services Block Grant and CDC can give greater
priority to preconception health and offer support for dem-
onstration projects and evaluations of prevention programs.
Whereas federally funded Healthy Start projects are required
to have interconception health activities, these projects, lo-
cated in communities with high infant mortality, provide
opportunities to offer more systematic preconception screen-
ing, health promotion, and interventions. Publicly funded
programs that offer screening and related services for STDs
and HIV/AIDS also might provide risk assessment and health
promotion interventions. Title X, WIC, Title V, Healthy Start,
and other public health programs also provide a setting to
test and evaluate new approaches to improve preconception
health (44,187).
Strategies to promote dialogue and action among commu-
nity members for a geographically defined community or a
community of professionals can help advance these recom-
mendations and action steps (Box 8). Local task force groups
that involve consumer, community leaders, and health pro-
fessionals can help implement preconception strategies that
are similar to strategies used previously for other topics (e.g.,
adolescent pregnancy prevention and childhood vaccinations).
Functioning parallel to clinical practice collaboratives, pub-
lic health practice collaboratives that link local public health
programs can promote development and dissemination of
community-based best practices.
Recommendation 9. Research. Increase the evidence base
and promote the use of the evidence to improve preconception
health.
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191). At the state and local levels, PRAMS, Perinatal Periods
of Risk, Fetal-Infant Mortality Review, and youth risk behav-
ior surveys provide additional opportunities for the data col-
lection, analysis, and interpretation that comprise public health
surveillance (190,192–194).
The Maternal and Child Health Bureau, in cooperation
with states, operates the Title V data and information system,
which provides an opportunity to strengthen public health
surveillance and performance monitoring. A review of state-
selected performance measures and priority needs for 2006–
2010 indicated that a limited number of states are monitoring
trends for access to components of preconception and
interconception care, access to primary care for women of
childbearing age, unintended pregnancy, and other related
topics (175).
Since 1990, indicators and monitoring systems have been
used not only to assess programs at the population level but
also to measure the quality of health-care services. HEDIS is
an example of a set of measures commonly used by purchas-
ers of health-care coverage, including state Medicaid agencies
and employers. HEDIS includes indicators on prenatal and
postpartum care and family planning (195). New HEDIS
measures are needed to monitor access to, use of, and out-
comes of preconception care services as well as improved
maternal and infant health. The recommendations in this re-
port can be used as a frame work for developing or modifying
• Use federal and state agency support to encourage more
integrated preconception health practices in clinics and
programs.
• Provide support for CDC programs to develop, evalu-
ate, and disseminate integrated approaches to promote
preconception health.
• Analyze and evaluate the preconception care activities
used under the federal Healthy Start program, and sup-
port replication projects.
• Convene or use local task forces, coalitions, or com-
mittees to discuss opportunities for promotion and pre-
vention in preconception health at the community level.
• Develop and support public health practice collabora-
tive groups to promote shared learning and dissemina-
tion of approaches for increasing preconception health.
• Include content related to preconception care in educa-
tional curricula of schools of public health and other
training facilities for public health professionals.
Box 8. Recommendation 8 preconception health action steps
• Prepare an updated evidence-based systematic review
of all published reports on science, programs, and policy
(e.g., through the Agency for Healthcare Research and
Quality).
• Encourage and support evaluation of model programs
and projects, including integrated service delivery and
community health promotion projects.
• Conduct quantitative and qualitative studies to advance
knowledge of preconception risks and clinical and pub-
lic health interventions, including knowledge of more
integrated practice strategies and interconception ap-
proaches.
• Design and conduct analyses of cost-benefit and cost-
effectiveness as part of the study of preconception
interventions.
• Conduct health services research to explore barriers to
evidence-based and guidelines-based practice.
• Conduct studies to examine the factors that results in
variations in individual use of preconception care (i.e.,
barriers and motivators that affect health-care use).
Box 9. Recommendation 9 preconception health action steps
Additional evidence is needed regarding the effectiveness
of interventions, the value of better service integration, and
the potential cost benefit of preconception care for the gen-
eral population and for women at high risk for poor preg-
nancy outcomes. Evaluations of preconception health
programs and projects can help advance understanding of the
potential impact of selected approaches. For certain clinical
interventions (e.g., interventions to address multiple risk fac-
tors simultaneously or single risk factor interventions), ran-
domized clinical trials are warranted, although not all
preconception health interventions can be ethically tested in
this manner. Economic studies, particularly of clinical inter-
vention strategies, can support the case for wider dissemina-
tion of preconception care practices (188; Box 9).
Recommendation 10. Monitoring Improvements.
Maximize public health surveillance and related research
mechanisms to monitor preconception health.
Community health data are used systematically to conduct
public health surveillance to evaluate and improve health,
health programs, and health policy (187). Surveillance includes
monitoring the frequency of conditions, risk factors, services,
and outcomes. CDC and other public health agencies con-
duct surveillance and maintain data collection and surveil-
lance systems, and the field of maternal and child health
benefits from several of these systems. For example, PRAMS,
the Behavioral Risk Factor Surveillance System, and the Na-
tional Survey of Family Growth (NSFG) can be modified to
provide more data concerning preconception health (189–
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existing measures to monitor evidence-based interventions
used in preconception health services (Box 10).
Conclusion
The 10 recommendations for improving preconception care
services and the health of women and infants were developed
through a process of consultation with a select panel of spe-
cialists from the relevant disciplines. Implementation of the
recommendations will help achieve the SPPC vision of pre-
conception health and pregnancy outcomes in which 1)
women and men of childbearing age have high reproductive
awareness (i.e., understand risk factors related to childbear-
ing); 2) women and men have a reproductive life plan (e.g.,
whether or when they want to have children and how they
will maintain their reproductive health); 3) pregnancies are
intended and planned; 4) women and men of childbearing
age have health-care coverage; 5) women of childbearing age
are screened before pregnancy for risks related to the outcomes
of pregnancy; and 6) women with a previous adverse preg-
nancy outcome (e.g., infant death, very low birthweight or
preterm birth) have access to interconception care aimed at
reducing their risks.
Improving preconception health will require changes in the
knowledge and attitudes and behaviors of persons, families,
communities, and institutions (e.g., government and health-
care settings). The purpose of preconception care is to im-
prove the health of each woman before any pregnancy and
thereby affect the future health of the woman, her child, and
her family. The recommendations and specific action steps
were developed as a result of SPPC meeting and implementa-
tion of CDC’s preconception health programs. The frame
work has incorporated both an ecological model and a lifespan
perspective on health and recognized the unique contribu-
tions and challenges encountered by women, their families,
communities, and institutions. Improving the health of
women can increase the quality of health for families and the
community.
Several preconception care interventions have reduced risk
and improved health outcomes. By increasing support for pro-
vision of preconception care, policy makers have the oppor-
tunity to promote broad-based programs and services aimed
at improving the health of women, children, and families. The
recommendations present a conceptual frame work
for innovative service delivery models so that women are
afforded the benefit of risk-appropriate preconception services
during every encounter with the health-care system.
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American College of Obstetricians and Gynecologists
(ACOG)
American College of Osteopathic Obstetricians
and Gynecologists (ACOOG)
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Association of Asian Pacific Community Health
Organizations (AAPCHO)
Association of Maternal and Child Health Programs
(AMCHP)
Association of State and Territorial Health Officials
(ASTHO)
Associations of Women’s Health, Obstetric
and Neonatal Nurses (AWHONN)
CityMatCH
Healthy Start Coalition of Miami-Dade
March of Dimes (MOD)
March of Dimes Advisory Council
Maternity Center Association (MCA)
National Alliance for Hispanic Health
National Association of Community Health Centers
(NACHC)
National Association of County and City Health Officials
(NACCHO)
National Birth Defects Prevention Network (NBDPN)
National Foundation for Infectious Diseases
National Healthy Mothers, Healthy Babies Coalition
National Healthy Start Association (NHSA)
National Hispanic Medical Association (NHMA)
National Medical Association (NMA)
National Partnership to Help Pregnant Smokers Quit;
Smoke-Free Families
National Perinatal Association (NPA)
National Society of Genetic Counselors (NSGC)
Society for Maternal Fetal Medicine (SMFM)
Task Force for Child Survival and Development
The Jacobs Institute for Women’s Health (JIWH)
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E. All of the above.
4. Women with a previous adverse pregnancy outcome are at increased
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A. True.
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5. Preconception care is most important for women before the first
pregnancy and is not a priority for subsequent pregnancies.
A. True.
B. False.
6. The content of preconception care is the same for everyone.
A. True.
B. False.
7. Clinical medicine, public health, communities, individuals, and




8. One of the recommendations for improving preconception health is to








10. Several national surveillance systems provide estimates of the
frequency and content of preconception care visits.
A. True.
B. False.






12. I plan to use these recommendations as the basis for…(Indicate all
that apply.)
A. health education materials.
B. insurance reimbursement policies.
C. local practice guidelines.
D. public policy.
E. other.
13. Overall, the length of the journal report was…
A. much too long.
B. a little too long.
C. just right.
D. a little too short.
E. much too short.
14. After reading this report, I am confident I can describe the need for













16. After reading this report, I am confident I can list the 10








































































































































































































































































































































































































































































































































































































































































































































































































































































































































18. After reading this report, I am confident I can describe the







19. After reading this report, I am confident I can describe the






20. After reading this report, I am confident I can describe areas of













22. The instructional strategies used in this report (text, boxes, and
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Correct answers for questions 1–10.
1. B; 2. D; 3. E; 4. A; 5. B; 6. B; 7. A; 8. A; 9. B; 10. B


















27. The availability of continuing education credit influenced my












29. Do you feel this course was commercially biased? (Indicate yes or no;
if yes, please explain in the space provided.)
A. Yes.
B. No.
30. How did you learn about the continuing education activity?
A. Internet.
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